So, we have a healthcare analyst looking at Pfizer's missteps on obesity drugs, by which I mean injuring people, with adverse side effects effecting nearly ¾ of test subjects.
So, what is a the response of a highly respected financial adviser on Wall Street, to ask, "Is it time to buy Pfizer yet?"
Seriously, a 73%+ (the 73% is just for nausea, when you roll in the vomiting and diarrhea it undoubtedly goes higher) adverse side effect rate, and you are wondering if it's time to buy?
Something is very wrong with incentives in society.
0 comments :
Post a Comment